

DividendAtlas
DividendAtlas is a dividend research and portfolio tracking platform built for European retail investors.
Cost / License
- Freemium (Subscription)
- Proprietary
Application type
Platforms
- Online
- Software as a Service (SaaS)
Features
- Goal Tracking
- Dark Mode
- Support for multiple currencies
- Ad-free
- Import CSV Data
- Portfolio Management
- Investment Tracking
DividendAtlas News & Activities
Recent activities
- DividendAtlas added DividendAtlas
DividendAtlas added DividendAtlas as alternative to getquin, Sharesight, Stock Events Market Tracker and MerryDiv
DividendAtlas information
What is DividendAtlas?
DividendAtlas is a dividend research and portfolio tracking platform built for European retail investors.
Most dividend tools are designed for Americans. They don't support European brokers, their dividend data is US-centric, and their tax and currency handling assumes a US account. DividendAtlas is built the other way round.
Import — one-click portfolio import from DeGiro, Trading 212, Interactive Brokers and Nordnet, plus generic CSV for any other broker.
Dividend Health Score — every stock gets a 1-99 safety score built from payout sustainability, dividend coverage, balance sheet strength and dividend cut history, with separate models for REITs and for banks and insurers.
Valuation — fair value estimates comparing today's multiple against the company's own five-year history, across P/E, P/B, P/S, EV/EBITDA, P/FCF and dividend yield.
Verified data — dividend records are checked against company filings, with corrections applied on every data refresh rather than as one-off patches.
Built for Europe — EUR-native with support for USD, GBP, CHF, SEK, NOK, DKK, PLN and CAD. Dividend growth is computed on fiscal year boundaries, and dividends paid in a currency other than the listing currency are converted at the rate on the payment date.
Free plan: 25 holdings, one portfolio, and the complete dividend feature set including history, growth rates, yield on cost, projections, the events calendar and the health score. Plus: €7.99/month or €79.90/year for unlimited holdings across five portfolios, full fundamentals, ten-year price history and CSV export.







